← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Feb 17

Insider

Name

Collins Helen Louise

Title

CHIEF MEDICAL OFFICER

CIK

0001701247

Roles

Officer

Transaction Details

Transaction Date

2026-02-12

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 1/4th of the RSUs will vest on March 1, 2027 and 1/16th of the RSUs will vest each June 1, September 1, December 1, and March 1 thereafter, subject to the Reporting Person continuing as a service provider through each such date. | 1/4th of the shares subject to the option will vest on February 12, 2027 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Filing Info

Accession No.

0001701247-26-000001

Form Type

4

Issuer CIK

0001672619

Collins Helen Louise's History

Date Ticker Type Value
2026-04-17 ELVN M $12K
2026-04-17 ELVN $6K
2026-04-17 ELVN $115K
2026-04-17 ELVN $117K
2026-04-17 ELVN M $0
2026-03-25 ELVN M $99K
2026-03-25 ELVN $1.4M
2026-03-25 ELVN M $0
2026-02-17 ELVN M $112K
2026-02-17 ELVN $1.2M

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$2.8M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
2026-02-12
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12